Associated Papers
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
Gómez Tejeda Zañudo J et al.
Nature Communications, 2024
38503755 (PubMed )
Supplement: 41467_2024_45835_MOESM7_ESM.xlsx › Mutation_calls_-_WES
A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3.
Paul MS et al.
American Journal of Human Genetics, 2024
Select a paper to view details